|
Aug 7
|
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
|
|
Aug 6
|
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
|
|
Aug 6
|
Broker Revenue Forecasts For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging Higher
|
|
Aug 6
|
Recursion Sets $100 Million Partnership Goal by 202
|
|
Aug 5
|
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
|
|
Aug 5
|
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 5
|
Recursion Pharmaceuticals: Q2 Earnings Snapshot
|
|
Aug 5
|
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Aug 4
|
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
|
|
Aug 3
|
2 Beaten-Down Stocks With Incredible Upside Potential
|
|
Aug 2
|
Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month
|
|
Jul 31
|
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jul 30
|
Recursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Jul 29
|
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
|
|
Jul 28
|
Why Recursion Pharmaceuticals Stock Got Mashed on Monday
|
|
Jul 26
|
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
|
|
Jul 25
|
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
|
|
Jul 23
|
Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses?
|
|
Jul 22
|
Recursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings
|
|
Jul 21
|
Why Is Recursion Pharma Stock Surging On Monday?
|